Related Experiment Video
Updated: Apr 30, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Risk of bias in randomized trials of pharmacological interventions in children and adults
Yashwant K Sinha1, Jonathan C Craig2, Premala Sureshkumar3
1Center for Kidney Research, The Children's Hospital at Westmead, Westmead, Australia.
Insights
Pediatric randomized controlled trials show a similar risk of bias compared to adult trials when matched for drug class and therapeutic area. This indicates no inherent difference in the capacity to conduct high-quality research between pediatric and adult studies.
Area of Science:
- Clinical Trials
- Pediatric Research
- Pharmacology
Background:
- Assessing the quality of evidence from clinical trials is crucial for informed medical decision-making.
- Concerns exist regarding potential biases in randomized controlled trials (RCTs) involving pediatric populations compared to adults.
- Understanding these differences is vital for advancing pediatric pharmacologic interventions.
Purpose of the Study:
- To compare the risk of bias in pediatric pharmacologic RCTs with similar adult trials.
- To investigate whether disparities in trial quality exist between pediatric and adult research.
Main Methods:
- A systematic review and matched-pair comparison of pediatric and adult RCTs published in MEDLINE (January 2008-October 2009).
- Trials were matched by drug class and therapeutic area.
- The Cochrane risk of bias tool was employed for assessment.
Main Results:
- Pediatric and adult trials exhibited similar characteristics, with adult studies more frequently conducted in Europe and published in specialty journals.
- A significant proportion of trials, both pediatric and adult, had an unclear risk of bias for allocation concealment.
- While initial analysis suggested a lower risk of bias in pediatric trials for random sequence generation and blinding, a sensitivity analysis indicated publication year as a confounder.
Conclusions:
- When matched for key characteristics, pediatric and adult RCTs demonstrate comparable risks of bias.
- Differences in reported bias are not attributable to variations in researchers' capacity to conduct high-quality trials.
- The findings support the potential for high-quality evidence generation in pediatric pharmacology research.
Objective:
To determine whether randomized controlled trials of pharmacologic interventions in children are more likely to be biased than similar trials in adults.
Study Design:
Trials involving only children and published in MEDLINE between January 2008 and October 2009 (n=100) were randomly selected and matched, by drug class and therapeutic area, with a similar trial completed in adults. The Cochrane risk of bias tool was used to compare the pediatric and adult trials.
Results:
The characteristics of adult and pediatric trials included were similar, except that adult studies were more likely to be conducted in Europe and published in specialty journals. Two-thirds of all trials were single center, and 62% had 100 or fewer participants. Many trials had an unclear risk of bias for allocation concealment (65% adult, 52% pediatric). More pediatric trials had a low risk of bias for random sequence generation (59% pediatric, 41% adult, P=.002) and blinding of outcome assessment (63% pediatric, 48% adult, P=.04) than adult trials; however, a sensitivity analysis of trials published since 2008 (and so matched by year of publication) did not confirm this finding, suggesting year of publication was an important confounder.
Conclusions:
When randomized controlled trials are matched for drug class and therapeutic area, trials involving children display a similar risk of bias. Differences in the risk of bias between pediatric and adult trials are not caused by differences in the capacity of researchers to conduct and report trials of high quality.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blinding
Randomized Experiments
Simple randomization
Simple...
Bias in Epidemiological Studies
Blind Procedures
Clinical Trials
There are four phases in a clinical trial. A phase one...

